• 1  Wagner G, Fenchel K, Back W, Schulz A, Sachse MM. Leukemia cutis – epidemiology, clinical presentation, and differential diagnoses. J Dtsch Dermatol Ges 2012;10:27–36. Pubmed link
  • 2  Benet C, Gomez A, Aguilar C, et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol 2011;135:278–90.*** Cross Ref link Pubmed link
  • 3  Su WP. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 1994;13:223–30. Pubmed link
  • 4  Cerroni L, Zenahlik P, Hofler G, Kaddu S, Smolle J, Kerl H. Specific cutaneous infiltrates of B‐cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 1996;20:1000–10. Cross Ref link Pubmed link
  • 5  Agis H, Weltermann A, Fonatsch C, et al. A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol 2002;81:90–5. Cross Ref link Pubmed link
  • 6  Liu PI, Ishimaru T, McGregor DH, Okada H, Steer A. Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima–Nagasaki 1949–1969. Cancer 1973;31:948–55. Cross Ref link Pubmed link
  • 7  Wiernik PH, Serpick AA. Granulocytic sarcoma (chloroma). Blood 1970;35:361–9. Pubmed link
  • 8  Vitte F, Fabiani B, Benet C, et al. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol 2012;36:1302–16. Cross Ref link Pubmed link
  • 9  Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ, Variakojis D. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 1993;11:690–7. Pubmed link
  • 10  Siegel RS, Gartenhaus RB, Kuzel TM. Human T‐cell lymphotropic‐I‐associated leukemia/lymphoma. Curr Treat Options Oncol 2001;2:291–300. Cross Ref link Pubmed link
  • 11  Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC. T‐cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism. J Am Acad Dermatol 2006;55:467–77. Cross Ref link Pubmed link
  • 12  Cho‐Vega JH, Medeiros LJ, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol 2008;129:130–42.*** Cross Ref link Pubmed link
  • 13  Resnik KS, Brod BB. Leukemia cutis in congenital leukemia. Analysis and review of the world literature with report of an additional case. Arch Dermatol 1993;129:1301–6. Cross Ref link Pubmed link
  • 14  Clark WB, Strickland SA, Barrett AJ, Savani BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 2010;95:860–3. Cross Ref link Pubmed link
  • 15  Petrella T, Meijer CJ, Dalac S, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK‐cell lymphomas) and leukemia cutis. Am J Clin Pathol 2004;122:307–13. Cross Ref link Pubmed link
  • 16  Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood 2011;118:3785–93. Cross Ref link Pubmed link
  • 17  Kaddu S, Zenahlik P, Beham‐Schmid C, Kerl H, Cerroni L. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol 1999;40:966–78. Cross Ref link Pubmed link
  • 18  Klco JM, Welch JS, Nguyen TT, et al. State of the art in myeloid sarcoma. Int J Lab Hematol 2011;33:555–65. Cross Ref link Pubmed link
  • 19  Paydas S, Zorludemir S, Sahin B. Vasculitis and leukemia. Leuk Lymphoma 2000;40:105–12. Cross Ref link Pubmed link
  • 20  Mathew RA, Bennett JM, Liu JJ, et al. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leuk Res 2012;36:72–80. Cross Ref link Pubmed link
  • 21  Cronin DM, George TI, Sundram UN. An updated approach to the diagnosis of myeloid leukemia cutis. Am J Clin Pathol 2009;132:101–10. Cross Ref link Pubmed link
  • 22  Robak E, Robak T. Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma 2007;48:855–65. Cross Ref link Pubmed link
  • 23  Smith JL Jr, Butler JJ. Skin involvement in Hodgkin's disease. Cancer 1980;45:354–61. Cross Ref link Pubmed link
  • 24  Roglin J, Boer A. Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. Br J Dermatol 2007;157:16–25. Cross Ref link Pubmed link
  • 25  Beaty MW, Toro J, Sorbara L, et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol 2001;25:1111–20. Cross Ref link Pubmed link
  • 26  Sander CA, Flaig MJ, Jaffe ES. Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. World Health Organization. Clin Lymphoma 2001;2:86–100; discussion 1–2. Cross Ref link Pubmed link
  • 27  Cerroni L, Beham‐Schmid C, Kerl H. Cutaneous Hodgkin's disease: an immunohistochemical analysis. J Cutan Pathol 1995;22:229–35. Cross Ref link Pubmed link
  • 28  Rajkumar SV, Kyle RA, Buadi FK. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc 2010;85:945–8. Cross Ref link Pubmed link
  • 29  Kyle RA, Therneau TM, Dispenzieri A, et al. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk 2013;13:184–6. Cross Ref link Pubmed link
  • 30  Molina‐Ruiz AM, Pulpillo A, Lasanta B, Zulueta T, Andrades R, Requena L. A rare case of primary cutaneous plasmacytoma‐like lymphoproliferative disorder following renal transplantation. J Cutan Pathol 2012;39:685–9. Cross Ref link Pubmed link
  • 31  Requena L, Kutzner H, Palmedo G, et al. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases. Arch Dermatol 2003;139:475–86. Cross Ref link Pubmed link
  • 32  Sun X, Peterson LC, Gong Y, Traynor AE, Nelson BP. Post‐transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients. Mod Pathol 2004;17:389–94. Cross Ref link Pubmed link
  • 33  Patterson JW, Parsons JM, White RM, Fitzpatrick JE, Kohout‐Dutz E. Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma. J Am Acad Dermatol 1988;19:879–90. Cross Ref link Pubmed link
  • 34  Abdel‐Wahab OI, Levine RL. Primary myelofibrosis: update on definition, pathogenesis, and treatment. Annu Rev Med 2009;60:233–45. Cross Ref link Pubmed link
  • 35  Haniffa MA, Wilkins BS, Blasdale C, Simpson NB. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders. J Am Acad Dermatol 2006;55:S28–31. Cross Ref link Pubmed link
  • 36  O'Malley DP. Benign extramedullary myeloid proliferations. Mod Pathol 2007;20:405–15. Cross Ref link Pubmed link
  • 37  Nappi O, Boscaino A, Wick MR. Extramedullary hematopoietic proliferations, extraosseous plasmacytomas, and ectopic splenic implants (splenosis). Semin Diagn Pathol 2003;20:338–56. Cross Ref link Pubmed link
  • 38  Rongioletti F, Patterson JW, Rebora A. The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies. J Cutan Pathol 2008;35:705–21.*** Cross Ref link Pubmed link
  • 39  Daoud MS, Lust JA, Kyle RA, Pittelkow MR. Monoclonal gammopathies and associated skin disorders. J Am Acad Dermatol 1999;40:507–35; quiz 36–8. Cross Ref link Pubmed link
  • 40  Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol 2012;39:962–70. Cross Ref link Pubmed link
  • 41  Chattopadhyay M, Rytina E, Dada M, Bhogal BS, Groves R, Handfield‐Jones S. Immunobullous dermatosis associated with Waldenstrom macroglobulinaemia treated with rituximab. Clin Exp Dermatol 2013;38:866–9. Cross Ref link Pubmed link
  • 42  Whittaker SJ, Bhogal BS, Black MM. Acquired immunobullous disease: a cutaneous manifestation of IgM macroglobulinaemia. Br J Dermatol 1996;135:283–6. Cross Ref link Pubmed link
  • 43  West NY, Fitzpatrick JE, David‐Bajar KM, Bennion SD. Waldenstrom macroglobulinemia‐induced bullous dermatosis. Arch Dermatol 1998;134:1127–31. Cross Ref link Pubmed link
  • 44  Rosenzweig M, Landau H. Light chain (AL) amyloidosis: update on diagnosis and management. J Hematol Oncol 2011;4:47. Cross Ref link Pubmed link
  • 45  Requena L, Sarasa JL, Ortiz Masllorens F, et al. Follicular spicules of the nose: a peculiar cutaneous manifestation of multiple myeloma with cryoglobulinemia. J Am Acad Dermatol 1995;32:834–9. Cross Ref link Pubmed link
  • 46  Ramos‐Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012;379:348–60. Cross Ref link Pubmed link
  • 47  Krug B, Sonet A, Pirson AS, Mahy N, Bosly A, Borght TV. FDG PET utility in paraneoplastic sweet syndrome. Clin Nucl Med 2004;29:91–2. Cross Ref link Pubmed link
  • 48  Linke R, Voltz R. FDG‐PET in paraneoplastic syndromes. Recent Results Cancer Res 2008;170:203–11. Cross Ref link Pubmed link
  • 49  Wu LM, Chen FY, Jiang XX, Gu HY, Yin Y, Xu JR. 18F‐FDG PET, combined FDG‐PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta‐analysis. Eur J Radiol 2012;81:303–11. Cross Ref link Pubmed link
  • 50  Fogo A, du Vivier A. The cutaneous manifestations of haematological malignancy. Clin Med 2009;9:366–70.*** Cross Ref link
  • 51  Raza S, Kirkland RS, Patel AA, Shortridge JR, Freter C. Insight into Sweet's syndrome and associated‐malignancy: a review of the current literature. Int J Oncol 2013;42:1516–22. Pubmed link
  • 52  Anzalone CL, Cohen PR. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Curr Opin Hematol 2013;20:26–35. Cross Ref link Pubmed link
  • 53  Kluger N, Gil‐Bistes D, Guillot B, Bessis D. Efficacy of anti‐interleukin‐1 receptor antagonist anakinra (Kineret(R)) in a case of refractory Sweet's syndrome. Dermatology 2011;222:123–7. Cross Ref link Pubmed link
  • 54  Delluc A, Limal N, Puechal X, Frances C, Piette JC, Cacoub P. Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Ann Rheum Dis 2008;67:278–9. Cross Ref link Pubmed link
  • 55  Bourke JF, Jones JL, Fletcher A, Graham‐Brown RA. An immunohistochemical study of the dermal infiltrate and epidermal staining for interleukin 1 in 12 cases of Sweet's syndrome. Br J Dermatol 1996;134:705–9. Cross Ref link Pubmed link
  • 56  Oskay T, Anadolu R. Sweet's syndrome in familial Mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF. J Cutan Pathol 2009;36:901–5. Cross Ref link Pubmed link
  • 57  Jo T, Horio K, Migita K. Sweet's syndrome in patients with MDS and MEFV mutations. N Engl J Med 2015;372:686–8. Cross Ref link Pubmed link
  • 58  Kroshinsky D, Alloo A, Rothschild B, et al. Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol 2012;67:945–54. Cross Ref link Pubmed link
  • 59  Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol 2013;68:1006–15. Cross Ref link Pubmed link
  • 60  Galaria NA, Junkins‐Hopkins JM, Kligman D, James WD. Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited. J Am Acad Dermatol 2000;43:870–4. Cross Ref link Pubmed link
  • 61  Willard RJ, Turiansky GW, Genest GP, Davis BJ, Diehl LF. Leukemia cutis in a patient with chronic neutrophilic leukemia. J Am Acad Dermatol 2001;44:365–9. Cross Ref link Pubmed link
  • 62  Sakiyama M, Kobayashi T, Nagata Y, Fujimoto N, Satoh T, Tajima S. Bullous pyoderma gangrenosum: a case report and review of the published work. J Dermatol 2012;39:1010–15. Cross Ref link Pubmed link
  • 63  Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000;79:37–46. Cross Ref link Pubmed link
  • 64  Koester G, Tarnower A, Levisohn D, Burgdorf W. Bullous pyoderma gangrenosum. J Am Acad Dermatol 1993;29:875–8. Cross Ref link Pubmed link
  • 65  Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004;43:790–800. Cross Ref link Pubmed link
  • 66  Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol 1983;9:751–8. Cross Ref link Pubmed link
  • 67  Duguid CM, O'Loughlin S, Otridge B, Powell FC. Paraneoplastic pyoderma gangrenosum. Australas J Dermatol 1993;34:17–22. Cross Ref link Pubmed link
  • 68  Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin Dermatol 2000;18:319–30. Cross Ref link Pubmed link
  • 69  Ng ES, Aw DC, Tan KB, et al. Neutrophilic eccrine hidradenitis associated with decitabine. Leuk Res 2010;34:e130–2. Cross Ref link Pubmed link
  • 70  Marini M, Wright D, Ropolo M, Abbruzzese M, Casas G. Neutrophilic eccrine hidradenitis secondary to topotecan. J Dermatolog Treat 2002;13:35–7. Cross Ref link Pubmed link
  • 71  Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011;29:419–25, viii. Cross Ref link Pubmed link
  • 72  Vezzoli P, Berti E, Marzano AV. Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Exp Rev Clin Immunol 2008;4:351–64. Cross Ref link
  • 73  Barzilai A, Shpiro D, Goldberg I, et al. Insect bite‐like reaction in patients with hematologic malignant neoplasms. Arch Dermatol 1999;135:1503–7. Cross Ref link Pubmed link
  • 74  Bairey O, Goldschmidt N, Ruchlemer R, et al. Insect‐bite‐like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group. Eur J Haematol 2012;89:491–6. Cross Ref link Pubmed link
  • 75  Vassallo C, Passamonti F, Cananzi R, et al. Exaggerated insect bite‐like reaction in patients affected by oncohaematological diseases. Acta Derm Venereol 2005;85:76–7. Cross Ref link Pubmed link
  • 76  Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol 2006;24:493–7. Cross Ref link
  • 77  Heymann WR. Scleromyxedema. J Am Acad Dermatol 2007;57:890–1. Cross Ref link Pubmed link
  • 78  Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37–43. Cross Ref link Pubmed link
  • 79  Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 2014;20:332–42. Cross Ref link Pubmed link
  • 80  Rongioletti F, Merlo G, Cinotti E, et al. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol 2013;69:66–72. Cross Ref link Pubmed link
  • 81  Canueto J, Labrador J, Roman C, et al. The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights. Eur J Haematol 2012;88:450–4. Cross Ref link Pubmed link
  • 82  Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 2006;35:355–9. Cross Ref link Pubmed link
  • 83  Angeli‐Besson C, Koeppel MC, Jacquet P, Andrac L, Sayag J. Electron‐beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol 1994;130:394–7. Cross Ref link Pubmed link
  • 84  Rimon D, Lurie M, Storch S, et al. Cardiomyopathy and multiple myeloma. Complications of scleredema adultorum. Arch Intern Med 1988;148:551–3. Cross Ref link Pubmed link
  • 85  Curtis AC, Shulak BM. Scleredema adultorum. Not always a benign self‐limited disease. Arch Dermatol 1965;92:526–41. Cross Ref link Pubmed link
  • 86  Aarden L, Ruuls SR, Wolbink G. Immunogenicity of anti‐tumor necrosis factor antibodies – toward improved methods of anti‐antibody measurement. Curr Opin Immunol 2008;20:431–5. Cross Ref link Pubmed link
  • 87  Hager CM, Sobhi HA, Hunzelmann N, et al. Bath‐PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998;38:240–2. Cross Ref link Pubmed link
  • 88  Aichelburg MC, Loewe R, Schicher N, et al. Successful treatment of poststreptococcal scleredema adultorum Buschke with intravenous immunoglobulins. Arch Dermatol 2012;148:1126–8. Cross Ref link Pubmed link
  • 89  Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008;59:1017–30. Cross Ref link Pubmed link
  • 90  Stables GI, Taylor PC, Highet AS. Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis. Br J Dermatol 2000;142:781–3. Cross Ref link Pubmed link
  • 91  Szturz P, Adam Z, Vasku V, et al. Complete remission of multiple myeloma associated scleredema after bortezomib‐based treatment. Leuk Lymphoma 2013;54:1324–6. Cross Ref link Pubmed link
  • 92  Szalat R, Arnulf B, Karlin L, et al. Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. Blood 2011;118:3777–84. Cross Ref link Pubmed link
  • 93  Spicknall KE, Mehregan DA. Necrobiotic xanthogranuloma. Int J Dermatol 2009;48:1–10. Cross Ref link Pubmed link
  • 94  Chave TA, Chowdhury MM, Holt PJ. Recalcitrant necrobiotic xanthogranuloma responding to pulsed high‐dose oral dexamethasone plus maintenance therapy with oral prednisolone. Br J Dermatol 2001;144:158–61. Cross Ref link Pubmed link
  • 95  Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010;23:590–6. Cross Ref link Pubmed link
  • 96  Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med 2009;361:1415–16. Cross Ref link Pubmed link
  • 97  Inan S, Cowan A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Biochem Behav 2006;85:39–43. Cross Ref link Pubmed link
  • 98  Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006;54:527–31. Cross Ref link Pubmed link
  • 99  Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002;43:2083–92.*** Cross Ref link Pubmed link
  • 100  Fain O, Braun T, Stirnemann J, Fenaux P. [Systemic and autoimmune manifestations in myelodysplastic syndromes.] Rev Med Interne 2011;32:552–9. Cross Ref link Pubmed link
  • 101  Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483–9. Cross Ref link Pubmed link
  • 102  Zent CS, Kay NE. Autoimmune complications in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 2010;23:47–59. Cross Ref link Pubmed link
  • 103  Lulla P, Bandeali S, Baker K. Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2011;11 Suppl. 1:S14–16. Cross Ref link
  • 104  Pavlidis NA, Klouvas G, Tsokos M, Bai M, Moutsopoulos HM. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders – a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 1995;16:477–82. Cross Ref link Pubmed link
  • 105  Stone MJ, Merlini G, Pascual V. Autoantibody activity in Waldenstrom's macroglobulinemia. Clin Lymphoma 2005;5:225–9. Cross Ref link Pubmed link
  • 106  Jadidi‐Niaragh F, Ghalamfarsa G, Yousefi M, Tabrizi MH, Shokri F. Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions. Tumour Biol 2013;34:2031–9. Cross Ref link Pubmed link
  • 107  Simon A, Asli B, Braun‐Falco M, et al. Schnitzler's syndrome: diagnosis, treatment, and follow‐up. Allergy 2013;68:562–8. Cross Ref link Pubmed link
  • 108  Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol 2013;161:303–15. Cross Ref link Pubmed link
  • 109  D'Souza A, Hayman SR, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow‐up of patients with POEMS syndrome. Blood 2011;118:4663–5. Cross Ref link Pubmed link
  • 110  Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk‐stratification, and management. Am J Hematol 2011;86:591–601. Cross Ref link Pubmed link
  • 111  Lipsker D, Rondeau M, Massard G, Grosshans E. The AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage. Medicine 2003;82:51–9. Cross Ref link Pubmed link
  • 112  Sykes DB, Schroyens W, O'Connell C. The TEMPI syndrome – a novel multisystem disease. N Engl J Med 2011;365:475–7. Cross Ref link Pubmed link
  • 113  Schroyens W, O'Connell C, Sykes DB. Complete and partial responses of the TEMPI syndrome to bortezomib. N Engl J Med 2012;367:778–80. Cross Ref link Pubmed link
  • 114  Kwok M, Korde N, Landgren O. Bortezomib to treat the TEMPI syndrome. N Engl J Med 2012;366:1843–5. Cross Ref link Pubmed link
  • 115  Side L, Taylor B, Cayouette M, et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997;336:1713–20. Cross Ref link Pubmed link
  • 116  Side LE, Emanuel PD, Taylor B, et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998;92:267–72. Pubmed link
  • 117  Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol 1995;131:904–8. Cross Ref link Pubmed link
  • 118  Karalis A, Tischkowitz M, Millington GW. Dermatological manifestations of inherited cancer syndromes in children. Br J Dermatol 2011;164:245–56.*** Cross Ref link Pubmed link
  • 119  Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet 2011;204:227–44. Cross Ref link Pubmed link
  • 120  Chiu CF, Chow KC, Lin TY, Tsai MH, Shih CM, Chen LM. Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein–Barr virus, type I human T‐cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol 2000;113:774–81. Cross Ref link Pubmed link
  • 121  Seno A, Torigoe R, Shimoe K, Tada J, Arata J, Suwaki M. Kikuchi's disease (histiocytic necrotizing lymphadenitis) with cutaneous involvement. J Am Acad Dermatol 1994;30:504–6. Cross Ref link Pubmed link
  • 122  Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol 1995;19:798–809. Cross Ref link Pubmed link
  • 123  Park HS, Sung MJ, Park SE, Lim YT. Kikuchi–Fujimoto disease of 16 children in a single center of Korea. Pediatr Allergy Immunol 2007;18:174–8. Cross Ref link Pubmed link
  • 124  Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2004;28:505–13. Cross Ref link Pubmed link
  • 125  Sun QF, Xu DZ, Pan SH, et al. Kimura disease: review of the literature. Intern Med J 2008;38:668–72. Cross Ref link Pubmed link
  • 126  O'Malley DP, Grimm KE. Reactive lymphadenopathies that mimic lymphoma: entities of unknown etiology. Semin Diagn Pathol 2013;30:137–45.*** Cross Ref link Pubmed link
  • 127  Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7:19–73. Pubmed link
  • 128  Foucar E, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. Current status and future directions. Arch Dermatol 1988;124:1211–14. Cross Ref link Pubmed link
  • 129  Tjiu JW, Hsiao CH, Tsai TF. Cutaneous Rosai–Dorfman disease: remission with thalidomide treatment. Br J Dermatol 2003;148:1060–1. Cross Ref link Pubmed link
  • 130  Nasseri E, Belisle A, Funaro D. Rosai–Dorfman disease treated with methotrexate and low‐dose prednisone: case report and review of the literature. J Cutan Med Surg 2012;16:281–5. Pubmed link
  • 131  Cheuk W, Chan JK. IgG4‐related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010;17:303–32. Cross Ref link Pubmed link
  • 132  Cheuk W, Chan JK. Lymphadenopathy of IgG4‐related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 2012;29:226–34. Cross Ref link Pubmed link
  • 133  Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4‐related disease. Mod Pathol 2012;25:1181–92. Cross Ref link Pubmed link
  • 134  Sillevis Smitt JH, Wulffraat NM, Kuijpers TW. The skin in primary immunodeficiency disorders. Eur J Dermatol 2005;15:425–32.*** Pubmed link
  • 135  Conti HR, Baker O, Freeman AF, et al. New mechanism of oral immunity to mucosal candidiasis in hyper‐IgE syndrome. Mucosal Immunol 2011;4:448–55. Cross Ref link Pubmed link
  • 136  Summers PR. Topical therapy for mucosal yeast infections. Curr Probl Dermatol 2011;40:48–57. Cross Ref link Pubmed link
  • 137  Boisson‐Dupuis S, Kong XF, Okada S, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol 2012;24:364–78. Cross Ref link Pubmed link
  • 138  Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL‐17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 2012;12:616–22. Cross Ref link Pubmed link
  • 139  Hoeger PH, Harper JI. Neonatal erythroderma: differential diagnosis and management of the “red baby”. Arch Dis Child 1998;79:186–91. Cross Ref link Pubmed link
  • 140  Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin‐17 immunity. Science 2011;332:65–8. Cross Ref link Pubmed link
  • 141  Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin‐1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009;361:1760–7. Cross Ref link Pubmed link
  • 142  Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009;361:1727–35. Cross Ref link Pubmed link
  • 143  Lanternier F, Pathan S, Vincent QB, et al. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med 2013;369:1704–14. Cross Ref link Pubmed link
  • 144  Edeer Karaca N, Boisson‐Dupuis S, Aksu G, et al. Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN‐gamma receptor‐1 deficiency. Immunotherapy 2012;4:1121–7. Cross Ref link Pubmed link
  • 145  de Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL‐12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010;89:381–402. Cross Ref link Pubmed link
  • 146  Liu L, Okada S, Kong XF, et al. Gain‐of‐function human STAT1 mutations impair IL‐17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011;208:1635–48. Cross Ref link Pubmed link
  • 147  Aldave JC, Cachay E, Nunez L, et al. A 1‐year‐old girl with a gain‐of‐function STAT1 mutation treated with hematopoietic stem cell transplantation. J Clin Immunol 2013;33:1273–5. Cross Ref link Pubmed link
  • 148  Burbelo PD, Browne SK, Sampaio EP, et al. Anti‐cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010;116:4848–58. Cross Ref link Pubmed link
  • 149  Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003;56:12–16. Cross Ref link Pubmed link
  • 150  Browne SK, Holland SM. Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol 2010;10:534–41.*** Cross Ref link Pubmed link
  • 151  Kisand K, Boe Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17‐associated cytokines. J Exp Med 2010;207:299–308. Cross Ref link Pubmed link
  • 152  Puel A, Doffinger R, Natividad A, et al. Autoantibodies against IL‐17A, IL‐17F, and IL‐22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010;207:291–7. Cross Ref link Pubmed link
  • 153  Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult‐onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012;367:725–34. Cross Ref link Pubmed link
  • 154  de Beaucoudrey L, Puel A, Filipe‐Santos O, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL‐17‐producing T cells. J Exp Med 2008;205:1543–50. Cross Ref link Pubmed link
  • 155  Doffinger R, Helbert MR, Barcenas‐Morales G, et al. Autoantibodies to interferon‐gamma in a patient with selective susceptibility to mycobacterial infection and organ‐specific autoimmunity. Clin Infect Dis 2004;38:e10–14. Cross Ref link Pubmed link
  • 156  Dorman SE, Holland SM. Interferon‐gamma and interleukin‐12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321–33. Cross Ref link Pubmed link
  • 157  Rosenzweig SD, Dorman SE, Uzel G, et al. A novel mutation in IFN‐gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004;173:4000–8. Cross Ref link Pubmed link
  • 158  Sato S. Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol 1991;10:313–19. Pubmed link
  • 159  Dawson AA, Ogston D, Fullerton HW. Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J 1969;3:436–9. Cross Ref link Pubmed link
  • 160  Takkunen H. Iron‐deficiency pruritus. JAMA 1978;239:1394. Cross Ref link Pubmed link
  • 161  Piskin S, Sayan C, Durukan N, Senol M. Serum iron, ferritin, folic acid, and vitamin B12 levels in recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 2002;16:66–7. Cross Ref link Pubmed link
  • 162  Lu SY, Wu HC. Initial diagnosis of anemia from sore mouth and improved classification of anemias by MCV and RDW in 30 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:679–85. Cross Ref link Pubmed link
  • 163  Bartolucci P, Brugnara C, Teixeira‐Pinto A, et al. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood 2012;120:3136–41. Cross Ref link Pubmed link
  • 164  Gniadecka M, Gniadecki R, Serup J, Sondergaard J. Microvascular reactions to postural changes in patients with sickle cell anaemia. Acta Derm Venereol 1994;74:191–3. Pubmed link
  • 165  Marti‐Carvajal AJ, Knight‐Madden JM, Martinez‐Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database Syst Rev 2012;11:CD008394. Pubmed link
  • 166  Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol 2013;160:434–44. Cross Ref link Pubmed link
  • 167  Fast LD. Developments in the prevention of transfusion‐associated graft‐versus‐host disease. Br J Haematol 2012;158:563–8. Cross Ref link Pubmed link
  • 168  Six CK, Haught JM, Safyan EL, Patton T, Stahlfeld K. Transfusion‐associated graft‐versus‐host disease: a case report and review of literature. J Am Acad Dermatol 2012;66:e141–3.*** Cross Ref link Pubmed link
  • 169  Lubenow N, Eichler P, Albrecht D, et al. Very low platelet counts in post‐transfusion purpura falsely diagnosed as heparin‐induced thrombocytopenia. Report of four cases and review of literature. Thromb Res 2000;100:115–25. Cross Ref link Pubmed link
  • 170  Taaning E, Svejgaard A. Post‐transfusion purpura: a survey of 12 Danish cases with special reference to immunoglobulin G subclasses of the platelet antibodies. Transfus Med 1994;4:1–8. Cross Ref link Pubmed link
  • 171  Waters AH. Post‐transfusion purpura. Blood Rev 1989;3:83–7. Cross Ref link Pubmed link